Ident. | Authors (with country if any) | Title |
---|
000518 (2020) |
B. Robson [Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. |
000546 (????) |
Manisha Prajapat [Inde] ; Phulen Sarma [Inde] ; Nishant Shekhar [Inde] ; Pramod Avti [Inde] ; Shweta Sinha [Inde] ; Hardeep Kaur [Inde] ; Subodh Kumar [Inde] ; Anusuya Bhattacharyya [Inde] ; Harish Kumar [Inde] ; Seema Bansal [Inde] ; Bikash Medhi [Inde] | Drug targets for corona virus: A systematic review. |
000670 (2020) |
Shan Lu [États-Unis] | Timely development of vaccines against SARS-CoV-2. |
000815 (2020) |
Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
000857 (2020) |
Ting Xiao [République populaire de Chine] ; Jia-Fan Tang [République populaire de Chine] ; Ge Meng [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Yuan-Yuan Zhu [République populaire de Chine] ; Gen-Yan Liu [République populaire de Chine] ; Zhi-Qiang Xu [République populaire de Chine] ; Feng-Shou Wu [République populaire de Chine] ; Shuang-Xi Gu [République populaire de Chine] ; Fen-Er Chen [République populaire de Chine] | Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities. |
000872 (2019) |
Yichao Wan [République populaire de Chine] ; Yuanhua Li [République populaire de Chine] ; Chunxing Yan [République populaire de Chine] ; Mi Yan [République populaire de Chine] ; Zilong Tang [République populaire de Chine] | Indole: A privileged scaffold for the design of anti-cancer agents. |
000930 (2019) |
Ren-Jun Wu [République populaire de Chine] ; Kai-Xuan Zhou [République populaire de Chine] ; Haijin Yang [République populaire de Chine] ; Guo-Qing Song [République populaire de Chine] ; Yong-Hong Li [République populaire de Chine] ; Jia-Xin Fu [République populaire de Chine] ; Xiao Zhang [République populaire de Chine] ; Shu-Jing Yu [République populaire de Chine] ; Li-Zhong Wang [République populaire de Chine] ; Li-Xia Xiong [République populaire de Chine] ; Cong-Wei Niu [République populaire de Chine] ; Fu-Hang Song [République populaire de Chine] ; Haitao Yang [République populaire de Chine] ; Jian-Guo Wang [République populaire de Chine] | Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives. |
000942 (2019) |
Zhao Wang [République populaire de Chine] ; Zhao Yu [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Ye Tian [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs. |
000986 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
000988 (2018) |
Alicia Regueiro-Ren ; Jacob J. Swidorski ; Zheng Liu ; Yan Chen ; Ny Sin ; Sing-Yuen Sit ; Jie Chen ; Brian L. Venables ; Juliang Zhu ; Beata Nowicka-Sans ; Tricia Protack ; Zeyu Lin ; Brian Terry ; Himadri Samanta ; Sharon Zhang ; Zhufang Li ; John Easter ; Brett R. Beno ; Vinod Arora ; Xiaohua S. Huang ; Sandhya Rahematpura ; Dawn D. Parker ; Roy Haskell ; Kenneth S. Santone ; Mark I. Cockett ; Mark Krystal ; Nicholas A. Meanwell ; Susan Jenkins ; Umesh Hanumegowda ; Ira B. Dicker | Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176). |
000A14 (2018) |
Xueyi Lu [République populaire de Chine] ; Jiapei Yang [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Ping Gao [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2. |
000A29 (2018) |
Zhongxia Zhou [République populaire de Chine] ; Tao Liu ; Dongwei Kang ; Zhipeng Huo ; Gaochan Wu ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong Liu | Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel". |
000A82 (2017) |
Woo-Jin Shin [États-Unis] ; Baik Lin Seong [Corée du Sud] | Type II transmembrane serine proteases as potential target for anti-influenza drug discovery. |
000B31 (2017) |
Lu Yu [République populaire de Chine] ; Xiuhai Gan [République populaire de Chine] ; Dagui Zhou [République populaire de Chine] ; Fangcheng He [République populaire de Chine] ; Song Zeng [République populaire de Chine] ; Deyu Hu [République populaire de Chine] | Synthesis and Antiviral Activity of Novel 1,4-Pentadien-3-one Derivatives Containing a 1,3,4-Thiadiazole Moiety. |
000C00 (2017) |
Xiao Li [République populaire de Chine] ; Ping Gao [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Zhongxia Zhou [République populaire de Chine] ; Zhao Yu [République populaire de Chine] ; Zheng Yuan [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement. |
000C30 (2016) |
M S Yip ; H L Leung ; P H Li ; C Y Cheung ; I. Dutry ; D. Li ; M. Daëron [France] ; R. Bruzzone [France] ; J Sm Peiris ; M. Jaume | Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. |
000C54 (2015) |
Xiao-Yun Zeng ; Lu Lu ; Shi-Bo Jiang ; Shu-Wen Liu | [Small molecular agents against MERS-CoV infection]. |
000C55 (2015) |
Shuai Xia ; Qian Wang ; Shu-Wen Liu ; Lu Lu ; Shi-Bo Jiang | [Development of peptidic MERS-CoV entry inhibitors]. |
000C80 (2016) |
Qing Meng [République populaire de Chine] ; Xuwang Chen [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Wenxin Li [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket. |
000C81 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
000C88 (2016) |
Fenghua Wang [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Kailin Yang [États-Unis] ; Haitao Yang [République populaire de Chine] | Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design. |